Patent · US Active

Dihydroorotate dehydrogenase inhibitors

US9006454B2 · kind B2 · utility

0Cited by
8References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2010
Grant dateApr 14, 2015
Priority date
Expiry dateDec 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I) wherein R1, R2, X1, X2, Y, Ra, Rb, Q have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis and also in the treatment of cancer disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.